Literature DB >> 8183311

Non-sequence-specific antimalarial activity of oligodeoxynucleotides.

D L Clark1, L A Chrisey, J R Campbell, E A Davidson.   

Abstract

The effects of exogenously applied oligodeoxynucleotides on Plasmodium falciparum proliferation was investigated. A fluorescence-activated cell sorter assay was employed to measure parasitemia after administration of either phosphodiester or phosphorothioate oligodeoxynucleotides. We report sequence-independent antimalarial activity preferentially with phosphorothioate congeners with IC50 values in the 1-2 microM range. Phosphorothioate oligodeoxynucleotides which were antisense, sense or nonsense to Plasmodium mRNA, as well as homopolymers (30-mers containing all A or T bases) were equally effective inhibitors of parasitemia. The antimalarial activity was dependent upon oligomer length, concentration, and time of addition to the cultures but was independent of the parasite strain tested. Four P. falciparum strains, including a multi-drug-resistant strain (MDR-K), a drug-sensitive strain (FCR-3), a erythrocyte membrane sialic acid-independent strain (7G8) and a strain isolated from a cerebral malaria patient (CM-87) were equally susceptible to treatment with a phosphorothioate oligomer. Inhibition of red cell invasion is primarily responsible for the observed decrease in proliferation as determined by a study of parasite maturation in the presence of a 30-mer nonsense phosphorothioate oligodeoxynucleotide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8183311     DOI: 10.1016/0166-6851(94)90015-9

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  6 in total

1.  Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria.

Authors:  Ivo M B Francischetti; Carlo J Oliveira; Graciela R Ostera; Stephanie B Yager; Françoise Debierre-Grockiego; Vanessa Carregaro; Giovanna Jaramillo-Gutierrez; Jen C C Hume; Lubin Jiang; Samuel E Moretz; Christina K Lin; José M C Ribeiro; Carole A Long; Brandi K Vickers; Ralph T Schwarz; Karl B Seydel; Massimo Iacobelli; Hans C Ackerman; Prakash Srinivasan; Regis B Gomes; Xunde Wang; Robson Q Monteiro; Michail Kotsyfakis; Anderson Sá-Nunes; Michael Waisberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

2.  Extrachromosomal, homologous expression of trypanothione reductase and its complementary mRNA in Trypanosoma cruzi.

Authors:  J Tovar; A H Fairlamb
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

3.  Saccharide anions as inhibitors of the malaria parasite.

Authors:  D L Clark; S Su; E A Davidson
Journal:  Glycoconj J       Date:  1997-06       Impact factor: 2.916

4.  Ribozyme cleavage of Plasmodium falciparum gyrase A gene transcript affects the parasite growth.

Authors:  Anwar Ahmed; Yagya D Sharma
Journal:  Parasitol Res       Date:  2008-06-05       Impact factor: 2.289

5.  Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides.

Authors:  R H Barker; V Metelev; E Rapaport; P Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

6.  Use of peptide nucleic acids to manipulate gene expression in the malaria parasite Plasmodium falciparum.

Authors:  Netanel Kolevzon; Abed Nasereddin; Shankar Naik; Eylon Yavin; Ron Dzikowski
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.